Maximizing Antiretroviral Therapy in Developing Countries: The Dual Challenge of Efficiency and Quality

JAMA. 2015 Jan 27;313(4):359-60. doi: 10.1001/jama.2014.16376.

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy
  • Acquired Immunodeficiency Syndrome / epidemiology
  • Adult
  • Anti-HIV Agents / economics
  • Anti-HIV Agents / therapeutic use*
  • Developing Countries
  • Drug Costs
  • Global Health
  • Guideline Adherence
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology
  • Humans
  • Incidence
  • Outcome Assessment, Health Care

Substances

  • Anti-HIV Agents